Wendy Chung insider trades
Open-market stock purchases and sales by Wendy Chung, Director at Prime Medicine, Inc, from SEC Form 4 filings since Aug 1, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 5, 2026 | PRME Prime Medicine, Inc | Bought (not open market) | — |